Our Expertise

As a firm focused on biomedical corporate development, we stand apart with exceptionally strong expertise in:

Seasoned judgment and design of clinical development approaches by our full-time physician executives with first-hand multicenter trial experience in industry and academic settings.

Rational product price forecasting that transcends comparable and conjoint analysis with integrated pharmacoeconomic modeling of cost-utility, cost-of-illness, payer-stratified reimbursement, and value-based pricing.

Achieving forward visibility into the commercial arena by validating product bases of value, endpoint acceptance, and competitive share dynamics with:

• Global, in-depth clinician roundtables and interviews
• Confidential industry executive interviews
• Discussion panels among: formulary and materials managers; P&T, capital equipment, GPO, and coding committee members; and HCFA, state-sponsored, and private insurance carriers.

FDA approvability and GMP requirement assessment by our certified regulatory affairs professionals with first-hand experience in leading successful approvals and quality system implementations.

Comprehensive pro forma financial modeling with our integrated suite of models that link:

• Multi-scenario efficacy and price-based potential market models
• U.S. and worldwide market penetration and revenue models, benchmarked by product group and vertical industry sector
• Preclinical and clinical development budgets by product program that achieve key approval, marketing, and post-marketing endpoints
• Corporate budgets by department that achieve key milestones of value
• Forecasts of enterprise earnings, earnings dilution, and cash flow
• Multi-scenario equity and debt-financed capital structure and balance sheet forecasts
• State-of-the-art valuation models employing discounted cash flow (including FCFF), real options (including compound and switching options), and comparable (including milestone-based) methodologies.